{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:23:39Z","timestamp":1788384219302,"version":"build-2803163510"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Angiotensin II (Ang II) plays a critical role in the progression of kidney disease. In addition to its direct signaling events, Ang II transactivates epidermal growth factor receptor (EGFR) and causes renal injury. CD148 is a transmembrane protein tyrosine phosphatase that dephosphorylates EGFR and strongly inhibits its activity. In this study, we have asked if CD148 agonistic antibody 18E1 mAb attenuates renal injury induced by chronic Ang II infusion to explore its therapeutic application.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Hypertensive nephropathy was induced in mice subjected to unilateral nephrectomy (UNx) by infusing Ang II (1.4\u00a0mg\/kg per day) for 6\u00a0weeks using an osmotic minipump. The 18E1 mAb or isotype control IgG were intraperitoneally injected (15\u00a0mg\/kg, three times per week) to the UNx\u2009+\u2009Ang II mice for 6\u00a0weeks, and their renal phenotype was investigated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Chronic Ang II infusion induced evident hypertension and renal injury that is indicated by elevation of plasma creatinine, urinary albumin excretion, renal hypertrophy, podocyte injury, macrophage infiltration, and the expression of alpha smooth muscle actin and collagen deposition. As compared with isotype control antibody, 18E1 mAb significantly reduced these renal changes, while it showed no effects on blood pressure. Furthermore, phospho-EGFR immunohistochemistry and immunoblotting demonstrated renal EGFR is activated in the mice that were subjected to UNx and Ang II infusion and 18E1 mAb significantly reduces EGFR phosphorylation in these kidneys as compared with isotype control treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Agonistic CD148 antibody attenuates UNx\u2009+\u2009Ang II\u2013induced renal injury, in part by reducing EGFR activity.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12882-025-04070-x","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T13:53:23Z","timestamp":1743429203000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["CD148 agonistic antibody alleviates renal injury induced by chronic angiotensin II infusion in mice"],"prefix":"10.1186","volume":"26","author":[{"given":"Keiko","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lejla","family":"Pasic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikage","family":"Narui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilly","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Ellinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Grundmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond C.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamune","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,31]]},"reference":[{"issue":"1","key":"4070_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ndt\/gfi265","volume":"21","author":"M Ruiz-Ortega","year":"2006","unstructured":"Ruiz-Ortega M, Ruperez M, Esteban V, Rodriguez-Vita J, Sanchez-Lopez E, Carvajal G, Egido J.Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases. Nephrol Dial Transplant. 2006;21(1):16\u201320.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"4070_CR2","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.amjmed.2003.09.034","volume":"116","author":"UC Brewster","year":"2004","unstructured":"Brewster UC, Perazella MA.The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease. Am J Med. 2004;116(4):263\u201372.","journal-title":"Am J Med"},{"key":"4070_CR3","doi-asserted-by":"publisher","first-page":"111259","DOI":"10.1016\/j.mce.2021.111259","volume":"529","author":"F Rianto","year":"2021","unstructured":"Rianto F, Hoang T, Revoori R, Sparks MA. Angiotensin receptors in the kidney and vasculature in hypertension and kidney disease. Mol Cell Endocrinol. 2021;529:111259.","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"4070_CR4","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.semnephrol.2007.01.009","volume":"27","author":"SB Gurley","year":"2007","unstructured":"Gurley SB, Coffman TM.The renin-angiotensin system and diabetic nephropathy. Semin Nephrol. 2007;27(2):144\u201352.","journal-title":"Semin Nephrol"},{"issue":"12","key":"4070_CR5","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1093\/ndt\/gfad118","volume":"38","author":"PI Georgianos","year":"2023","unstructured":"Georgianos PI, Agarwal R.Hypertension in chronic kidney disease-treatment standard 2023. Nephrol Dial Transplant. 2023;38(12):2694\u2013703.","journal-title":"Nephrol Dial Transplant"},{"key":"4070_CR6","doi-asserted-by":"publisher","first-page":"734917","DOI":"10.3389\/fphar.2021.734917","volume":"12","author":"K Verma","year":"2021","unstructured":"Verma K, Pant M, Paliwal S, Dwivedi J, Sharma S. An insight on multicentric signaling of angiotensin II in cardiovascular system: a recent update. Front Pharmacol. 2021;12:734917.","journal-title":"Front Pharmacol"},{"issue":"2","key":"4070_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.semnephrol.2003.11.009","volume":"24","author":"HM Siragy","year":"2004","unstructured":"Siragy HM.AT1 and AT2 receptor in the kidney: role in health and disease. Semin Nephrol. 2004;24(2):93\u2013100.","journal-title":"Semin Nephrol"},{"key":"4070_CR8","doi-asserted-by":"publisher","first-page":"702797","DOI":"10.3389\/fphys.2021.702797","volume":"12","author":"XC Li","year":"2021","unstructured":"Li XC, Wang CH, Leite APO, Zhuo JL. Intratubular, intracellular, and mitochondrial angiotensin II\/AT(1) (AT1a) receptor\/NHE3 signaling plays a critical role in angiotensin II-induced hypertension and kidney injury. Front Physiol. 2021;12:702797.","journal-title":"Front Physiol"},{"key":"4070_CR9","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1146\/annurev-pharmtox-070115-095427","volume":"56","author":"SJ Forrester","year":"2016","unstructured":"Forrester SJ, Kawai T, O\u2019Brien S, Thomas W, Harris RC, Eguchi S. Epidermal growth factor receptor transactivation: mechanisms, pathophysiology, and potential therapies in the cardiovascular system. Annu Rev Pharmacol Toxicol. 2016;56:627\u201353.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"6","key":"4070_CR10","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1681\/ASN.2005111163","volume":"17","author":"J Chen","year":"2006","unstructured":"Chen J, Chen JK, Neilson EG, Harris RC.Role of EGF receptor activation in angiotensin II-induced renal epithelial cell hypertrophy. J Am Soc Nephrol. 2006;17(6):1615\u201323.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"4070_CR11","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1128\/MCB.06410-11","volume":"32","author":"J Chen","year":"2012","unstructured":"Chen J, Chen JK, Harris RC.Angiotensin II induces epithelial-to-mesenchymal transition in renal epithelial cells through reactive oxygen species\/Src\/caveolin-mediated activation of an epidermal growth factor receptor-extracellular signal-regulated kinase signaling pathway. Mol Cell Biol. 2012;32(5):981\u201391.","journal-title":"Mol Cell Biol"},{"issue":"2","key":"4070_CR12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1681\/ASN.2011070645","volume":"23","author":"J Chen","year":"2012","unstructured":"Chen J, Chen JK, Nagai K, Plieth D, Tan M, Lee TC, Threadgill DW, Neilson EG, Harris RC.EGFR signaling promotes TGFbeta-dependent renal fibrosis. J Am Soc Nephrol. 2012;23(2):215\u201324.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"4070_CR13","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/MNH.0000000000000696","volume":"30","author":"RC Harris","year":"2021","unstructured":"Harris RC.The epidermal growth factor receptor axis and kidney fibrosis. Curr Opin Nephrol Hypertens. 2021;30(3):275\u201379.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"8","key":"4070_CR14","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/nrneph.2016.91","volume":"12","author":"LR Harskamp","year":"2016","unstructured":"Harskamp LR, Gansevoort RT, van Goor H, Meijer E.The epidermal growth factor receptor pathway in chronic kidney diseases. Nat Rev Nephrol. 2016;12(8):496\u2013506.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"4070_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.yexcr.2016.06.009","volume":"346","author":"L Sheng","year":"2016","unstructured":"Sheng L, Yang M, Ding W, Zhang M, Niu J, Qiao Z, Gu Y.Epidermal growth factor receptor signaling mediates aldosterone-induced profibrotic responses in kidney. Exp Cell Res. 2016;346(1):99\u2013110.","journal-title":"Exp Cell Res"},{"issue":"1-2","key":"4070_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.mce.2007.07.001","volume":"277","author":"C Grossmann","year":"2007","unstructured":"Grossmann C, Gekle M.Non-classical actions of the mineralocorticoid receptor: misuse of EGF receptors? Mol Cell Endocrinol. 2007;277(1-2):6\u201312.","journal-title":"Mol Cell Endocrinol"},{"key":"4070_CR17","doi-asserted-by":"publisher","first-page":"804212","DOI":"10.3389\/fonc.2022.804212","volume":"12","author":"Y Li","year":"2022","unstructured":"Li Y, Fu R, Jiang T, Duan D, Wu Y, Li C, Li Z, Ni R, Li L, Liu Y. Mechanism of lethal skin toxicities induced by epidermal growth factor receptor inhibitors and related treatment strategies. Front Oncol. 2022;12:804212.","journal-title":"Front Oncol"},{"key":"4070_CR18","doi-asserted-by":"publisher","first-page":"F647","DOI":"10.1152\/ajprenal.00288.2019","volume":"318","author":"K Takahashi","year":"2020","unstructured":"Takahashi K, Kim RH, Pasic L, He L, Nagasaka S, Katagiri D, May T, Shimizu A, Harris RC, Mernaugh RL, et al. Agonistic anti-CD148 monoclonal antibody attenuates diabetic nephropathy in mice. Am J Physiol Renal Physiol 2020;318:F647\u2013F659.","journal-title":"Am J Physiol Renal Physiol"},{"key":"4070_CR19","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/j.cub.2009.09.048","volume":"19","author":"G Tarcic","year":"2009","unstructured":"Tarcic G, Boguslavsky SK, Wakim J, Kiuchi T, Liu A, Reinitz F, Nathanson D, Takahashi T, Mischel PS, Ng T, et al. An unbiased screen identifies DEP-1 tumor suppressor as a phosphatase controlling EGFR endocytosis. Curr Biol 2009;19:1788\u201398.","journal-title":"Curr Biol"},{"key":"4070_CR20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.cels.2018.06.006","volume":"7","author":"A Stanoev","year":"2018","unstructured":"Stanoev A, Mhamane A, Schuermann KC, Grecco HE, Stallaert W, Baumdick M, Bruggemann Y, Joshi MS, Roda-Navarro P, Fengler S, et al. Interdependence between EGFR and phosphatases spatially established by vesicular dynamics generates a growth factor sensing and responding network. Cell Syst 2018;7:295\u2013309.e211.","journal-title":"Cell Syst"},{"issue":"6","key":"4070_CR21","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1073\/pnas.1106171109","volume":"109","author":"K Takahashi","year":"2012","unstructured":"Takahashi K, Mernaugh RL, Friedman DB, Weller R, Tsuboi N, Yamashita H, Quaranta V, Takahashi T.Thrombospondin-1 acts as a ligand for CD148 tyrosine phosphatase. Proc Natl Acad Sci USA. 2012;109(6):1985\u201390.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4070_CR22","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.7150\/jca.40955","volume":"11","author":"Y Sun","year":"2020","unstructured":"Sun Y, Li S, Yu W, Chen C, Liu T, Li L, Zhang D, Zhao Z, Gao J, Wang X, et al. CD148 serves as a prognostic marker of gastric cancer and hinders tumor progression by dephosphorylating EGFR. J Cancer 2020;11:2667\u201378.","journal-title":"J Cancer"},{"key":"4070_CR23","doi-asserted-by":"publisher","first-page":"e1566","DOI":"10.1002\/cnr2.1566","volume":"5","author":"L He","year":"2021","unstructured":"He L, Takahashi K, Pasic L, Narui C, Ellinger P, Grundmann M, Takahashi T. The effects of CD148 Q276P\/R326Q polymorphisms in A431D epidermoid cancer cell proliferation and epidermal growth factor receptor signaling. Cancer Rep (Hoboken). 2021;5:e1566.","journal-title":"Cancer Rep (Hoboken)"},{"issue":"5","key":"4070_CR24","doi-asserted-by":"publisher","first-page":"e0154916","DOI":"10.1371\/journal.pone.0154916","volume":"11","author":"K Takahashi","year":"2016","unstructured":"Takahashi K, Sumarriva K, Kim R, Jiang R, Brantley-Sieders DM, Chen J, Mernaugh RL, Takahashi T.Determination of the CD148-interacting region in thrombospondin-1. PLoS ONE. 2016;11(5):e0154916.","journal-title":"PLoS ONE"},{"issue":"1","key":"4070_CR25","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1128\/MCB.01374-08","volume":"29","author":"C Chabot","year":"2009","unstructured":"Chabot C, Spring K, Gratton JP, Elchebly M, Royal I.New role for the protein tyrosine phosphatase DEP-1 in Akt activation and endothelial cell survival. Mol Cell Biol. 2009;29(1):241\u201353.","journal-title":"Mol Cell Biol"},{"issue":"27","key":"4070_CR26","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1038\/sj.onc.1206652","volume":"22","author":"E Jandt","year":"2003","unstructured":"Jandt E, Denner K, Kovalenko M, Ostman A, Bohmer FD.The protein-tyrosine phosphatase DEP-1 modulates growth factor-stimulated cell migration and cell-matrix adhesion. Oncogene. 2003;22(27):4175\u201385.","journal-title":"Oncogene"},{"issue":"21","key":"4070_CR27","first-page":"16219","volume":"275","author":"M Kovalenko","year":"2000","unstructured":"Kovalenko M, Denner K, Sandstrom J, Persson C, Gross S, Jandt E, Vilella R, Bohmer F, Ostman A.Site-selective dephosphorylation of the platelet-derived growth factor beta-receptor by the receptor-like protein-tyrosine phosphatase DEP-1. JBiolChem. 2000;275(21):16219\u201326.","journal-title":"JBiolChem"},{"issue":"33","key":"4070_CR28","doi-asserted-by":"publisher","first-page":"22048","DOI":"10.1074\/jbc.M109.002758","volume":"284","author":"F Sacco","year":"2009","unstructured":"Sacco F, Tinti M, Palma A, Ferrari E, Nardozza AP, Hooft van Huijsduijnen R, Takahashi T, Castagnoli L, Cesareni G.Tumor suppressor density-enhanced phosphatase-1 (DEP-1) inhibits the RAS pathway by direct dephosphorylation of ERK1\/2 kinases. J Biol Chem. 2009;284(33):22048\u201358.","journal-title":"J Biol Chem"},{"key":"4070_CR29","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1196\/annals.1329.033","volume":"1030","author":"A Massa","year":"2004","unstructured":"Massa A, Barbieri F, Aiello C, Iuliano R, Arena S, Pattarozzi A, Corsaro A, Villa V, Fusco A, Zona G, et al. The phosphotyrosine phosphatase eta mediates somatostatin inhibition of glioma proliferation via the dephosphorylation of ERK1\/2. Ann N Y Acad Sci. 2004;1030:264\u201374.","journal-title":"Ann N Y Acad Sci"},{"issue":"7","key":"4070_CR30","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1128\/MCB.21.7.2393-2403.2001","volume":"21","author":"JE Baker","year":"2001","unstructured":"Baker JE, Majeti R, Tangye SG, Weiss A.Protein tyrosine phosphatase CD148-mediated inhibition of T-cell receptor signal transduction is associated with reduced LAT and phospholipase Cgamma1 phosphorylation. Mol Cell Biol. 2001;21(7):2393\u2013403.","journal-title":"Mol Cell Biol"},{"key":"4070_CR31","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1093\/carcin\/bgh224","volume":"25","author":"F Trapasso","year":"2004","unstructured":"Trapasso F, Yendamuri S, Dumon KR, Iuliano R, Cesari R, Feig B, Seto R, Infante L, Ishii H, Vecchione A, et al. Restoration of receptor-type protein tyrosine phosphatase eta function inhibits human pancreatic carcinoma cell growth in vitro and in vivo. Carcinogenesis 2004;25:2107\u201314.","journal-title":"Carcinogenesis"},{"issue":"1","key":"4070_CR32","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1042\/BJ20071317","volume":"413","author":"N Tsuboi","year":"2008","unstructured":"Tsuboi N, Utsunomiya T, Roberts RL, Ito H, Takahashi K, Noda M, Takahashi T.The tyrosine phosphatase CD148 interacts with the p85 regulatory subunit of phosphoinositide 3-kinase. Biochem J. 2008;413(1):193\u2013200.","journal-title":"Biochem J"},{"key":"4070_CR33","doi-asserted-by":"crossref","unstructured":"Young S, Struys E, Wood T. Quantification of creatine and guanidinoacetate using GC-MS and LC\u2013MS\/MS for the detection of cerebral creatine deficiency syndromes. Curr Protoc Hum Genet. 2007;54(1):17.3.1\u201317.3.18.","DOI":"10.1002\/0471142905.hg1703s54"},{"issue":"4","key":"4070_CR34","doi-asserted-by":"publisher","first-page":"F695","DOI":"10.1152\/ajprenal.00377.2015","volume":"311","author":"F Zeng","year":"2016","unstructured":"Zeng F, Kloepfer LA, Finney C, Diedrich A, Harris RC.Specific endothelial heparin-binding EGF-like growth factor deletion ameliorates renal injury induced by chronic angiotensin II infusion. Am J Physiol Renal Physiol. 2016;311(4):F695\u2013F707.","journal-title":"Am J Physiol Renal Physiol"},{"key":"4070_CR35","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1002\/mrm.27231","volume":"80","author":"F Wang","year":"2018","unstructured":"Wang F, Katagiri D, Li K, Takahashi K, Wang S, Nagasaka S, Li H, Quarles CC, Zhang MZ, Shimizu A, et al. Assessment of renal fibrosis in murine diabetic nephropathy using quantitative magnetization transfer MRI. Magn Reson Med 2018;80:2655\u201369.","journal-title":"Magn Reson Med"},{"key":"4070_CR36","doi-asserted-by":"publisher","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, Loughrey MB, Fernandez JA, Dombrowski Y, McArt DG, Dunne PD, McQuaid S, Gray RT, Murray LJ, Coleman HG, et al. QuPath: open source software for digital pathology image analysis. Sci Rep 2017;7:16878.","journal-title":"Sci Rep"},{"issue":"3","key":"4070_CR37","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/jb\/mvv045","volume":"158","author":"T Shintani","year":"2015","unstructured":"Shintani T, Higashi S, Takeuchi Y, Gaudio E, Trapasso F, Fusco A, Noda M.The R3 receptor-like protein tyrosine phosphatase subfamily inhibits insulin signalling by dephosphorylating the insulin receptor at specific sites. J Biochem. 2015;158(3):235\u201343.","journal-title":"J Biochem"},{"issue":"8","key":"4070_CR38","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/nm1275","volume":"11","author":"A Lautrette","year":"2005","unstructured":"Lautrette A, Li S, Alili R, Sunnarborg SW, Burtin M, Lee DC, Friedlander G, Terzi F.Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach. Nat Med. 2005;11(8):867\u201374.","journal-title":"Nat Med"},{"issue":"3","key":"4070_CR39","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1159\/000092196","volume":"103","author":"PJ Flannery","year":"2006","unstructured":"Flannery PJ, Spurney RF.Transactivation of the epidermal growth factor receptor by angiotensin II in glomerular podocytes. Nephron Exp Nephrol. 2006;103(3):e109\u2013118.","journal-title":"Nephron Exp Nephrol"},{"issue":"5","key":"4070_CR40","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.tips.2006.03.010","volume":"27","author":"BH Shah","year":"2006","unstructured":"Shah BH, Catt KJ.TACE-dependent EGF receptor activation in angiotensin-II-induced kidney disease. Trends Pharmacol Sci. 2006;27(5):235\u201337.","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"4070_CR41","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ajpath.2013.04.005","volume":"183","author":"J Tang","year":"2013","unstructured":"Tang J, Liu N, Tolbert E, Ponnusamy M, Ma L, Gong R, Bayliss G, Yan H, Zhuang S.Sustained activation of EGFR triggers renal fibrogenesis after acute kidney injury. Am J Pathol. 2013;183(1):160\u201372.","journal-title":"Am J Pathol"},{"issue":"10","key":"4070_CR42","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1016\/j.yexcr.2009.02.023","volume":"315","author":"RK Dave","year":"2009","unstructured":"Dave RK, Hume DA, Elsegood C, Kellie S.CD148\/DEP-1 association with areas of cytoskeletal organisation in macrophages. Exp Cell Res. 2009;315(10):1734\u201344.","journal-title":"Exp Cell Res"},{"key":"4070_CR43","doi-asserted-by":"crossref","unstructured":"Shalev M, Arman E, Stein M, Cohen-Sharir Y, Brumfeld V, Kapishnikov S, Royal I, Tuckermann J, Elson A. PTPRJ promotes osteoclast maturation and activity by inhibiting Cbl-mediated ubiquitination of NFATc1 in late osteoclastogenesis. FEBS J. 2021;288(15):4702\u201323.","DOI":"10.1111\/febs.15778"},{"key":"4070_CR44","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1165\/rcmb.2017-0088OC","volume":"58","author":"K Tsoyi","year":"2018","unstructured":"Tsoyi K, Chu SG, Patino-Jaramillo NG, Wilder J, Villalba J, Doyle-Eisele M, McDonald J, Liu X, El-Chemaly S, Perrella MA, et al. Syndecan-2 attenuates radiation-induced pulmonary fibrosis and inhibits fibroblast activation by regulating PI3K\/Akt\/ROCK pathway via CD148. Am J Respir Cell Mol Biol 2018;58:208\u201315.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"4070_CR45","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1164\/rccm.202008-3100OC","volume":"204","author":"K Tsoyi","year":"2021","unstructured":"Tsoyi K, Liang X, De Rossi G, Ryter SW, Xiong K, Chu SG, Liu X, Ith B, Celada LJ, Romero F, et al. CD148 deficiency in fibroblasts promotes the development of pulmonary fibrosis. Am J Respir Crit Care Med 2021;204:312\u201325.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"4070_CR46","doi-asserted-by":"publisher","first-page":"F12","DOI":"10.1152\/ajprenal.00112.2013","volume":"305","author":"A Staruschenko","year":"2013","unstructured":"Staruschenko A, Palygin O, Ilatovskaya DV, Pavlov TS.Epidermal growth factors in the kidney and relationship to hypertension. Am J Physiol Renal Physiol. 2013;305(1):F12\u201320.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"4070_CR47","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1172\/JCI113659","volume":"82","author":"RC Harris","year":"1988","unstructured":"Harris RC, Hoover RL, Jacobson HR, Badr KF.Evidence for glomerular actions of epidermal growth factor in the rat. J Clin Invest. 1988;82(3):1028\u201339.","journal-title":"J Clin Invest"},{"issue":"1","key":"4070_CR48","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1161\/01.RES.0000109413.57726.91","volume":"94","author":"L Hao","year":"2004","unstructured":"Hao L, Du M, Lopez-Campistrous A, Fernandez-Patron C.Agonist-induced activation of matrix metalloproteinase-7 promotes vasoconstriction through the epidermal growth factor-receptor pathway. Circ Res. 2004;94(1):68\u201376.","journal-title":"Circ Res"},{"issue":"3","key":"4070_CR49","first-page":"H976","volume":"276","author":"JA Florian","year":"1999","unstructured":"Florian JA, Watts SW.Epidermal growth factor: a potent vasoconstrictor in experimental hypertension. Am J Physiol. 1999;276(3):H976\u2013983.","journal-title":"Am J Physiol"},{"key":"4070_CR50","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1096\/fj.05-5328fje","volume":"20","author":"D Chansel","year":"2006","unstructured":"Chansel D, Ciroldi M, Vandermeersch S, Jackson LF, Gomez AM, Henrion D, Lee DC, Coffman TM, Richard S, Dussaule JC, et al. Heparin binding EGF is necessary for vasospastic response to endothelin. FASEB J 2006;20:1936\u201338.","journal-title":"FASEB J"},{"issue":"8","key":"4070_CR51","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1161\/01.CIR.0000030181.63741.56","volume":"106","author":"S Kagiyama","year":"2002","unstructured":"Kagiyama S, Eguchi S, Frank GD, Inagami T, Zhang YC, Phillips MI.Angiotensin II-induced cardiac hypertrophy and hypertension are attenuated by epidermal growth factor receptor antisense. Circulation. 2002;106(8):909\u201312.","journal-title":"Circulation"},{"key":"4070_CR52","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1681\/ASN.2012080839","volume":"24","author":"TS Pavlov","year":"2013","unstructured":"Pavlov TS, Levchenko V, O\u2019Connor PM, Ilatovskaya DV, Palygin O, Mori T, Mattson DL, Sorokin A, Lombard JH, Cowley Jr AW, et al. Deficiency of renal cortical EGF increases ENaC activity and contributes to salt-sensitive hypertension. J Am Soc Nephrol 2013;24:1053\u201362.","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"4070_CR53","doi-asserted-by":"publisher","first-page":"5223","DOI":"10.1074\/jbc.M112.407981","volume":"288","author":"N Pidkovka","year":"2013","unstructured":"Pidkovka N, Rao R, Mei S, Gong Y, Harris RC, Wang WH, Capdevila JH.Epoxyeicosatrienoic acids (EETs) regulate epithelial sodium channel activity by extracellular signal-regulated kinase 1\/2 (ERK1\/2)-mediated phosphorylation. J Biol Chem. 2013;288(7):5223\u201331.","journal-title":"J Biol Chem"},{"issue":"2","key":"4070_CR54","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/0006-291X(92)91298-5","volume":"187","author":"S Kanda","year":"1992","unstructured":"Kanda S, Igawa T, Sakai H, Nomata K, Kanetake H, Saito Y.Anti-epidermal growth factor antibody inhibits compensatory renal hyperplasia but not hypertrophy after unilateral nephrectomy in mice. Biochem Biophys Res Commun. 1992;187(2):1015\u201321.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"4070_CR55","doi-asserted-by":"publisher","first-page":"E362","DOI":"10.1152\/ajpendo.00007.2002","volume":"283","author":"A Flyvbjerg","year":"2002","unstructured":"Flyvbjerg A, Schrijvers BF, De Vriese AS, Tilton RG, Rasch R.Compensatory glomerular growth after unilateral nephrectomy is VEGF dependent. Am J Physiol Endocrinol Metab. 2002;283(2):E362\u2013366.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4070_CR56","doi-asserted-by":"publisher","first-page":"e40742","DOI":"10.1371\/journal.pone.0040742","volume":"7","author":"CE Smart","year":"2012","unstructured":"Smart CE, Askarian Amiri ME, Wronski A, Dinger ME, Crawford J, Ovchinnikov DA, Vargas AC, Reid L, Simpson PT, Song S, et al. Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors. PLoS ONE 2012;7:e40742.","journal-title":"PLoS ONE"},{"key":"4070_CR57","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2261-6-13","volume":"6","author":"A Lux","year":"2006","unstructured":"Lux A, Salway F, Dressman HK, Kroner-Lux G, Hafner M, Day PJ, Marchuk DA, Garland J. ALK1 signalling analysis identifies angiogenesis related genes and reveals disparity between TGF-beta and constitutively active receptor induced gene expression. BMC Cardiovasc Disord. 2006;6:13.","journal-title":"BMC Cardiovasc Disord"},{"issue":"6","key":"4070_CR58","doi-asserted-by":"publisher","first-page":"e68306","DOI":"10.1371\/journal.pone.0068306","volume":"8","author":"RK Dave","year":"2013","unstructured":"Dave RK, Dinger ME, Andrew M, Askarian-Amiri M, Hume DA, Kellie S.Regulated expression of PTPRJ\/CD148 and an antisense long noncoding RNA in macrophages by proinflammatory stimuli. PLoS ONE. 2013;8(6):e68306.","journal-title":"PLoS ONE"},{"issue":"5","key":"4070_CR59","doi-asserted-by":"publisher","first-page":"R108","DOI":"10.1186\/ar4288","volume":"15","author":"RK Dave","year":"2013","unstructured":"Dave RK, Naylor AJ, Young SP, Bayley R, Hardie DL, Haworth O, Rider DA, Cook AD, Buckley CD, Kellie S.Differential expression of CD148 on leukocyte subsets in inflammatory arthritis. Arthritis Res Therapy. 2013;15(5):R108.","journal-title":"Arthritis Res Therapy"},{"key":"4070_CR60","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1016\/j.mayocp.2019.05.031","volume":"94","author":"Y Qiao","year":"2019","unstructured":"Qiao Y, Shin JI, Sang Y, Inker LA, Secora A, Luo S, Coresh J, Alexander GC, Jackson JW, Chang AR, et al. Discontinuation of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease. Mayo Clin Proc 2019;94:2220\u201329.","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"4070_CR61","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.3109\/0886022X.2012.717478","volume":"34","author":"T Yildirim","year":"2012","unstructured":"Yildirim T, Arici M, Piskinpasa S, Aybal-Kutlugun A, Yilmaz R, Altun B, Erdem Y, Turgan C.Major barriers against renin-angiotensin-aldosterone system blocker use in chronic kidney disease stages 3\u20135 in clinical practice: a safety concern? Ren Fail. 2012;34(9):1095\u201399.","journal-title":"Ren Fail"},{"issue":"4","key":"4070_CR62","first-page":"e37813","volume":"15","author":"H Naveed","year":"2023","unstructured":"Naveed H, Tirumandyam G, Krishna Mohan GV, Gul S, Ali S, Siddiqui A, Suarez ZK, Khan A.Effect of discontinuation of renin angiotensin-system inhibitors in patients with advanced chronic kidney disease: a meta-analysis. Cureus. 2023;15(4):e37813.","journal-title":"Cureus"},{"issue":"5-6","key":"4070_CR63","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1159\/000531000","volume":"54","author":"C Tang","year":"2023","unstructured":"Tang C, Wen XY, Lv JC, Shi SF, Zhou XJ, Liu LJ, Zhang H.Discontinuation of renin-angiotensin system inhibitors and clinical outcomes in chronic kidney disease: a systemic review and meta-analysis. Am J Nephrol. 2023;54(5-6):234\u201344.","journal-title":"Am J Nephrol"},{"issue":"1","key":"4070_CR64","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/ndt\/gfl549","volume":"22","author":"LC Rump","year":"2007","unstructured":"Rump LC.Secondary rise of albuminuria under AT1-receptor blockade-what is the potential role of aldosterone escape? Nephrol Dial Transplant. 2007;22(1):5\u20138.","journal-title":"Nephrol Dial Transplant"},{"key":"4070_CR65","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.steroids.2014.05.017","volume":"91","author":"S Meinel","year":"2014","unstructured":"Meinel S, Gekle M, Grossmann C. Mineralocorticoid receptor signaling: crosstalk with membrane receptors and other modulators. Steroids. 2014;91:3\u201310.","journal-title":"Steroids"},{"key":"4070_CR66","doi-asserted-by":"crossref","unstructured":"Harris RC. The role of the epidermal growth factor receptor in diabetic kidney disease. Cells. 2022;11(21).","DOI":"10.3390\/cells11213416"},{"issue":"5","key":"4070_CR67","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/ki.2012.435","volume":"83","author":"J Tang","year":"2013","unstructured":"Tang J, Liu N, Zhuang S.Role of epidermal growth factor receptor in acute and chronic kidney injury. Kidney Int. 2013;83(5):804\u201310.","journal-title":"Kidney Int"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04070-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04070-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04070-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T18:07:45Z","timestamp":1743530865000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04070-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,31]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4070"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04070-x","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,31]]},"assertion":[{"value":"1 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments were carried out following the guidelines and regulations of Vanderbilt University. Animal experiments and procedures described in the present study were performed under the approval of the Vanderbilt University Animal Care and Use Committee and conducted in accordance with institutional guidelines. Anesthesia was monitored for its palpebral or eyelid reflex. The pedal or paw pinch reflex was also used. The toe was firmly pinched between the fingers to elicit a withdrawal response by the animal. The mice were monitored for breathing and reflex during surgery. Body weight of mice was measured weekly and mice that showed a decrease (>20 %) were considered for euthanasia. The mice were observed daily and unfavorable conditions such as sitting in the corner, no interest in food, and no grooming were also considered for euthanasia. Euthanasia was carried out by inhalation of carbon dioxide overdose and subsequent cervical dislocation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"Philipp Ellinger and Manuel Grundmann are full-time employees at Bayer AG. Other authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"165"}}